Barinthus Biotherapeutics plc annual net debt
2020
2021
2022
2023
2024
2025
Barinthus Biotherapeutics plc Net Debt Growth & History (BRNS)
Barinthus Biotherapeutics plc's net debt was −$59.2M for fiscal 2025.
View full Barinthus Biotherapeutics plc company overviewBarinthus Biotherapeutics plc annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$59.2M | $39.5M | — |
| 2024 | 2024-12-31 | −$98.7M | $30.5M | — |
| 2023 | 2023-12-31 | −$129.1M | $56.5M | — |
| 2022 | 2022-12-31 | −$185.6M | $21.2M | — |
| 2021 | 2021-12-31 | −$206.8M | −$165.2M | — |
| 2020 | 2020-12-31 | −$41.6M | — | — |
Barinthus Biotherapeutics plc quarterly net debt
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$49.0M | $25.3M | — |
| Q1 2026 | 2026-03-31 | −$54.9M | $32.3M | — |
| Q4 2025 | 2025-12-31 | −$59.2M | $39.5M | — |
| Q3 2025 | 2025-09-30 | −$62.7M | $30.7M | — |
| Q2 2025 | 2025-06-30 | −$74.3M | $30.9M | — |
| Q1 2025 | 2025-03-31 | −$87.2M | $30.0M | — |
| Q4 2024 | 2024-12-31 | −$98.7M | $30.5M | — |
| Q3 2024 | 2024-09-30 | −$93.4M | $54.2M | — |
| Q2 2024 | 2024-06-30 | −$105.2M | $55.6M | — |
| Q1 2024 | 2024-03-31 | −$117.2M | $63.5M | — |
| Q4 2023 | 2023-12-31 | −$129.1M | $56.5M | — |
| Q3 2023 | 2023-09-30 | −$147.6M | $44.2M | — |
| Q2 2023 | 2023-06-30 | −$160.9M | $22.9M | — |
| Q1 2023 | 2023-03-31 | −$180.7M | $13.2M | — |
| Q4 2022 | 2022-12-31 | −$185.6M | $21.2M | — |
| Q3 2022 | 2022-09-30 | −$191.8M | $33.9M | — |
| Q2 2022 | 2022-06-30 | −$183.7M | $58.3M | — |
| Q1 2022 | 2022-03-31 | −$193.9M | −$39.6M | — |
| Q4 2021 | 2021-12-31 | −$206.8M | −$165.2M | — |
| Q3 2021 | 2021-09-30 | −$225.7M | — | — |
| Q2 2021 | 2021-06-30 | −$242.0M | — | — |
| Q1 2021 | 2021-03-31 | −$154.3M | — | — |
| Q4 2020 | 2020-12-31 | −$41.6M | — | — |
Barinthus Biotherapeutics plc net debt trends
Over the last five fiscal years, Barinthus Biotherapeutics plc's net debt decreased from −$41.6M to −$59.2M, a change of −$17.6M. The latest reported quarter, Q2 2026, shows −$49.0M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Barinthus Biotherapeutics plc source filings ↗